Drug
Busulfan
Busulfan: highest development phase Phase 2, developed by Otsuka. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Otsuka
Trials
| Drug | Phase | Indication |
|---|---|---|
| Busulfan NCT00796562 | Phase 2 | MDS |
| Busulfan NCT02859402 | Phase 2 | T-cell Non-Hodgkin Lymphoma |
Latest
No recent events.
Follow Busulfan on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.